Caredx Inc sell nvestor
Start price
04.03.23
/
50%
€8.50
Target price
04.03.24
€4.00
Performance (%)
-13.49%
End price
16.09.23
€7.35
Summary
This prediction ended on 16.09.23 with a price of €7.35. The prediction for Caredx Inc closed with a convincing performance of -13.49%. nvestor has 50% into this predictionCareDx is a publicly traded biotechnology company that specializes in providing innovative transplant solutions for patients suffering from various diseases. The company has developed a range of diagnostic solutions that help doctors monitor the health of organ transplant recipients, including tests that can detect early signs of organ rejection. CareDx has a strong track record of developing cutting-edge medical technologies and working with leading healthcare providers to improve patient outcomes. As a publicly-listed company, CareDx has a diverse shareholder base and is subject to the scrutiny of regulatory bodies, providing transparency and accountability to investors.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Caredx Inc | 3.213% | 3.213% | -15.256% |
| iShares Core DAX® | 0.765% | 4.791% | 21.634% |
| iShares Nasdaq 100 | 1.418% | 3.133% | 5.422% |
| iShares Nikkei 225® | 0.658% | 0.972% | 15.333% |
| iShares S&P 500 | 1.310% | 2.279% | 3.125% |